These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2568783)

  • 1. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography.
    Wenzel-Hora BI; Potthoff PC; Jänicke UA
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():148-52. PubMed ID: 2568783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA; Pfennig D
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iotrolan, a nonionic dimeric contrast medium in myelography.
    Bien S; Schumacher M; Berger W; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():158-60. PubMed ID: 2568785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iotrolan versus iopamidol: a controlled, multicenter, double-blind study of lumbar and direct cervical myelography.
    Ringel K; Klotz E; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():153-7. PubMed ID: 2568784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to iotrolan after subarachnoid injection in animals.
    Press WR; Mützel W; Schöbel C
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():126-33. PubMed ID: 2568780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nonionic contrast agents iohexol and iotrolan for cisternal myelography in dogs.
    van Bree H; Van Rijssen B; Van Ham L
    Am J Vet Res; 1991 Jun; 52(6):926-33. PubMed ID: 1883098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience of iotrolan].
    Ishikawa M; Handa H
    Nihon Geka Hokan; 1986 May; 55(3):485-9. PubMed ID: 3800545
    [No Abstract]   [Full Text] [Related]  

  • 8. [A randomized, double-blind clinical trial of 2 nonionic contrast media for myelography].
    Lovrencić M; Klanfar Z; Jakovac I
    Lijec Vjesn; 1986 Apr; 108(4):141-6. PubMed ID: 3520199
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients.
    Hagen B; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical study with iotrolan versus metrizamide in lumbar myelography.
    Inoue S; Watanabe T; Yamamura H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():161-6. PubMed ID: 2568787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urography with monomeric and dimeric nonionic contrast media: comparative, randomized, double-blind study of iotrolan 280 and iopromide 300.
    Taenzer V; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():116-8. PubMed ID: 2568778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iohexol 240 mgr I/ml and metrizamide 240 mgr I/ml in lumbar myelography. Report from a randomized double blind study.
    Valk J; Hazenberg GJ; van Duijn H; Crezee F; Olislagers-De Slegte R
    Diagn Imaging Clin Med; 1986; 55(3):114-20. PubMed ID: 3522040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD; Bach-Gansmo T; Dahlstrom K
    Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural tolerance of iotrolan 300 in ascending cervical myelography: results of a multicenter study.
    Behrends B; Albrecht A; Bingas B; Becker H; Brunke J; von Einsiedel H; Mariss G; Schmidt K; Thun F; Valavanis A
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():171-5. PubMed ID: 2568789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.
    Nauert C; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():82-7. PubMed ID: 2568814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison of iotrolan and iohexol in lumbar myelography.
    Wagner A; Jensen C; Saebye A; Rasmussen TB
    Acta Radiol; 1994 Mar; 35(2):182-5. PubMed ID: 8172748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent development in non-ionic contrast media.
    Hagen B
    Ann Radiol (Paris); 1989; 32(1):38-9. PubMed ID: 2742324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iotrolan versus iopamidol for cervical myelography: a randomized double-blind trial.
    Coutinho C; McGeorge A; Macpherson P; Teasdale E
    Br J Radiol; 1988 Oct; 61(730):965-7. PubMed ID: 3056560
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording.
    Fiirgaard B; Madsen HH; Svare U; Eriksen FB; Skjødt T; Zeeberg I
    Acta Radiol; 1995 Jan; 36(1):77-81. PubMed ID: 7833174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modification of the image quality of i.v. DSA by the iodine concentration of the contrast medium].
    Langer M; Felix R; Keysser R; Speck U; Banzer D
    Digitale Bilddiagn; 1985 Sep; 5(3):154-9. PubMed ID: 3902326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.